Latest Supply Chain Challenges News

AFT Pharmaceuticals posted a 22% revenue jump to NZ$254.7 million and a 39% increase in operating profit to a record NZ$24.4 million for FY26, exceeding guidance. The company targets over NZ$300 million revenue for FY27, fueled by international expansion and a deepening R&D pipeline.

Challenger Gold's Pre-Feasibility Study for the Hualilan Project delivers a robust US$1.45 billion pre-tax NPV, 1.84 million ounces gold equivalent production, and a low upfront capital strategy.

Australian Strategic Materials Limited (ASM) shareholders are set to vote on a scheme of arrangement for Energy Fuels Inc. to acquire 100% of ASM shares and options, offering a significant premium and exposure to a vertically integrated rare earth supply chain.

ALS Limited reported a 25.8% jump in underlying net profit after tax to AUD 381.2 million for FY26, driven by strong commodity testing demand and margin expansion. The company raised its dividend and advanced major hub lab projects while navigating a post-year-end cyber incident.

Schoolblazer reports a modest revenue dip to $55.4m in 1H FY26 amid supply chain and geopolitical headwinds but strengthens its balance sheet with a new $110 million credit facility and advances integration efforts targeting profitability in FY27.

Amcor posted a 77% jump in Q3 net sales fueled by the Berry acquisition, delivering synergy gains above expectations and updating fiscal 2026 guidance amid geopolitical headwinds.

JB Hi-Fi posted modest sales growth in Australia and The Good Guys during Q3 FY26, while New Zealand sales declined amid rising supplier costs and stock shortages heading into a critical trading period.

Cavalier Resources has boosted the net present value of its Stage 1 Crawford Gold Project by 50% to A$77.2 million in an updated Pre-Feasibility Study, despite rising costs. The company secured a US$18.7 million gold sale agreement and raised $4 million to fund pre-production activities.

Cyprium Metals has made substantial progress on its Nifty Copper Complex restart, targeting copper cathode production by September 2026 while securing A$41 million to fuel exploration and growth.

CONNEQT Health’s Pulse device sales surged to a $7 million annualised run-rate despite a temporary supply hiccup, while the company manages a tight cash runway supported by new R&D loans and related-party funding.

Vitrafy Life Sciences completed Phase II of its U.S. Military platelet cryopreservation study with strong results for a simplified no-wash process, accelerating commercial interest and progressing FDA device registration despite manufacturing delays.

RLF AgTech has reported a record $18 million revenue for the nine months to March 2026, achieving positive EBITDA in March as it sharpens operational focus and expands its Australian sales footprint amid global fertiliser disruptions.